

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.22056157 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 4.96340591 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 4.53895384 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.36161804 |
| 5 | macrophage activation involved in immune response (GO:0002281) | 4.15834534 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.06470192 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.94891716 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.94891716 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.94891716 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.94891716 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.94891716 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.94891716 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94492641 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.88485648 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88485648 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.88006553 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79540868 |
| 18 | positive T cell selection (GO:0043368) | 3.76554196 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74420424 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.73518960 |
| 21 | sodium ion export (GO:0071436) | 3.71471994 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.60783383 |
| 23 | regulation of ARF protein signal transduction (GO:0032012) | 3.60036265 |
| 24 | activated T cell proliferation (GO:0050798) | 3.59841589 |
| 25 | regulation of B cell differentiation (GO:0045577) | 3.55769275 |
| 26 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51356116 |
| 27 | positive regulation of mast cell degranulation (GO:0043306) | 3.51356116 |
| 28 | negative T cell selection (GO:0043383) | 3.50079277 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.47045625 |
| 30 | thymic T cell selection (GO:0045061) | 3.44156642 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.40789676 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.39772880 |
| 33 | positive regulation of histone deacetylation (GO:0031065) | 3.32930717 |
| 34 | potassium ion import (GO:0010107) | 3.25542435 |
| 35 | cellular potassium ion homeostasis (GO:0030007) | 3.15494517 |
| 36 | serine transport (GO:0032329) | 3.14133499 |
| 37 | response to interleukin-15 (GO:0070672) | 3.09585046 |
| 38 | mannose metabolic process (GO:0006013) | 3.08511614 |
| 39 | neutrophil activation (GO:0042119) | 3.03025287 |
| 40 | leukocyte aggregation (GO:0070486) | 3.02691149 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.00642250 |
| 42 | natural killer cell differentiation (GO:0001779) | 3.00281610 |
| 43 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99852854 |
| 44 | cellular response to zinc ion (GO:0071294) | 2.96719781 |
| 45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95930243 |
| 46 | granulocyte activation (GO:0036230) | 2.94863222 |
| 47 | adaptation of signaling pathway (GO:0023058) | 2.93964050 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93482662 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.92354535 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92354535 |
| 51 | L-serine transport (GO:0015825) | 2.91884818 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 2.90684397 |
| 53 | tolerance induction (GO:0002507) | 2.89837323 |
| 54 | cortical actin cytoskeleton organization (GO:0030866) | 2.88360517 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 2.88199237 |
| 56 | locomotory exploration behavior (GO:0035641) | 2.87776021 |
| 57 | regulation of leukocyte degranulation (GO:0043300) | 2.84736781 |
| 58 | regulation of ARF GTPase activity (GO:0032312) | 2.84315489 |
| 59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.82181013 |
| 60 | positive regulation of Rap GTPase activity (GO:0032854) | 2.80071392 |
| 61 | negative regulation of bone resorption (GO:0045779) | 2.79881817 |
| 62 | protein localization to endosome (GO:0036010) | 2.78257422 |
| 63 | germ cell migration (GO:0008354) | 2.77908499 |
| 64 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.76110690 |
| 65 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74269766 |
| 66 | activation of JUN kinase activity (GO:0007257) | 2.72689991 |
| 67 | synaptic vesicle maturation (GO:0016188) | 2.72092662 |
| 68 | cell migration in hindbrain (GO:0021535) | 2.70584305 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 2.69836212 |
| 70 | regulation of defense response to virus by virus (GO:0050690) | 2.69637330 |
| 71 | negative regulation of glial cell proliferation (GO:0060253) | 2.68360894 |
| 72 | cellular response to prostaglandin stimulus (GO:0071379) | 2.67000268 |
| 73 | detection of other organism (GO:0098543) | 2.66172697 |
| 74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.66124135 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65750342 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 2.63885551 |
| 77 | positive regulation of macrophage cytokine production (GO:0060907) | 2.63016263 |
| 78 | histone H3-K36 demethylation (GO:0070544) | 2.61906476 |
| 79 | cellular response to interleukin-15 (GO:0071350) | 2.60323639 |
| 80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.59507641 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.59495568 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59320530 |
| 83 | macrophage activation (GO:0042116) | 2.58861032 |
| 84 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.58090923 |
| 85 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.58090923 |
| 86 | negative regulation of granulocyte differentiation (GO:0030853) | 2.58080419 |
| 87 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.57565261 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.56921718 |
| 89 | negative regulation of phagocytosis (GO:0050765) | 2.56572613 |
| 90 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.56001989 |
| 91 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.55628312 |
| 92 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.55628312 |
| 93 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.55628312 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 2.51616269 |
| 95 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.50788712 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50660502 |
| 97 | detection of bacterium (GO:0016045) | 2.49984513 |
| 98 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.49381156 |
| 99 | cellular extravasation (GO:0045123) | 2.47846681 |
| 100 | clathrin coat assembly (GO:0048268) | 2.46299806 |
| 101 | phospholipid dephosphorylation (GO:0046839) | 2.45143755 |
| 102 | positive regulation of bone resorption (GO:0045780) | 2.43736977 |
| 103 | positive regulation of bone remodeling (GO:0046852) | 2.43736977 |
| 104 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.42472751 |
| 105 | response to host immune response (GO:0052572) | 2.42431200 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.42431200 |
| 107 | cellular response to monoamine stimulus (GO:0071868) | 2.42339562 |
| 108 | cellular response to catecholamine stimulus (GO:0071870) | 2.42339562 |
| 109 | cortical cytoskeleton organization (GO:0030865) | 2.42017173 |
| 110 | I-kappaB phosphorylation (GO:0007252) | 2.40956655 |
| 111 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.40539633 |
| 112 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.40048425 |
| 113 | response to host (GO:0075136) | 2.40048425 |
| 114 | response to host defenses (GO:0052200) | 2.40048425 |
| 115 | negative regulation of T cell mediated immunity (GO:0002710) | 2.38373098 |
| 116 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.37204048 |
| 117 | dopamine receptor signaling pathway (GO:0007212) | 2.36212814 |
| 118 | positive regulation of regulated secretory pathway (GO:1903307) | 2.35751490 |
| 119 | peptidyl-lysine dimethylation (GO:0018027) | 2.35634815 |
| 120 | respiratory burst (GO:0045730) | 2.35433136 |
| 121 | T cell migration (GO:0072678) | 2.34534356 |
| 122 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34164223 |
| 123 | regulation of mast cell activation (GO:0033003) | 2.34000568 |
| 124 | regulation of Rap GTPase activity (GO:0032317) | 2.33671282 |
| 125 | regulation of macrophage cytokine production (GO:0010935) | 2.33355681 |
| 126 | neutrophil mediated immunity (GO:0002446) | 2.32754003 |
| 127 | regulation of platelet aggregation (GO:0090330) | 2.32407281 |
| 128 | pinocytosis (GO:0006907) | 2.32378244 |
| 129 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.31559039 |
| 130 | relaxation of cardiac muscle (GO:0055119) | 2.30826121 |
| 131 | positive regulation of protein deacetylation (GO:0090312) | 2.30336145 |
| 132 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.28954173 |
| 133 | T cell selection (GO:0045058) | 2.28711166 |
| 134 | negative regulation of type 2 immune response (GO:0002829) | 2.26805382 |
| 135 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.23918013 |
| 136 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.22081669 |
| 137 | regulation of glial cell proliferation (GO:0060251) | 2.20833202 |
| 138 | establishment of nucleus localization (GO:0040023) | 2.17636305 |
| 139 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.17293046 |
| 140 | hypothalamus development (GO:0021854) | 2.16864621 |
| 141 | signal complex assembly (GO:0007172) | 2.16860623 |
| 142 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.16530821 |
| 143 | B cell homeostasis (GO:0001782) | 2.16171123 |
| 144 | venous blood vessel morphogenesis (GO:0048845) | 2.15353054 |
| 145 | negative regulation of myotube differentiation (GO:0010832) | 2.13589271 |
| 146 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.13135058 |
| 147 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 2.12530125 |
| 148 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.11488617 |
| 149 | response to nerve growth factor (GO:1990089) | 2.11488617 |
| 150 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.11143510 |
| 151 | Peyers patch development (GO:0048541) | 2.11143510 |
| 152 | stress fiber assembly (GO:0043149) | 2.10356114 |
| 153 | regulation of tolerance induction (GO:0002643) | 2.10193854 |
| 154 | detection of external biotic stimulus (GO:0098581) | 2.09317069 |
| 155 | T cell homeostasis (GO:0043029) | 2.06533188 |
| 156 | response to parathyroid hormone (GO:0071107) | 2.06067156 |
| 157 | negative regulation of interleukin-12 production (GO:0032695) | 2.05917135 |
| 158 | negative regulation of innate immune response (GO:0045824) | 2.05008503 |
| 159 | regulation of beta-amyloid formation (GO:1902003) | 2.03335772 |
| 160 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.03132830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.34141772 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23678832 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.22038058 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.06972015 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.02293441 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85005566 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76058787 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74157732 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.72340699 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53339472 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.52951796 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.52232259 |
| 13 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.51491459 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.49192804 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.43379699 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.41717038 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38751189 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38675709 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37610623 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28936776 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.26366350 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25398101 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.14718848 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13936343 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02714561 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98460391 |
| 27 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.97821905 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97800664 |
| 29 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.96158621 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.95412782 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88625431 |
| 32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.84932111 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.81309125 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78005832 |
| 35 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75944900 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75289459 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73502015 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.69464908 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68596910 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.65919071 |
| 41 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.63983812 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63863084 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63658389 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63521639 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.58954785 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55796057 |
| 47 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55737328 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.53171573 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51720492 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50489687 |
| 51 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.49117687 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48700805 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47288388 |
| 54 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46540372 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43156368 |
| 56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42957609 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41533408 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40000397 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39940217 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39259338 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38687547 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38600056 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38264567 |
| 64 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.34731388 |
| 65 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33219170 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31506779 |
| 67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30307692 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25630992 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25368244 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24886455 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24117280 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23661038 |
| 73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22541809 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20964605 |
| 75 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20428677 |
| 76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19725300 |
| 77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18352777 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17734578 |
| 79 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.16963471 |
| 80 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.16963471 |
| 81 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16494395 |
| 82 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16271420 |
| 83 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15810408 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14877891 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14255145 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11296668 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10310476 |
| 88 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09812778 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09422960 |
| 90 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07868690 |
| 91 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07678562 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07676915 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07239664 |
| 94 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.06594359 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04503351 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03239714 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03213446 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02446057 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02418458 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 1.01426534 |
| 101 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01193430 |
| 102 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00765726 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.00461117 |
| 104 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00218363 |
| 105 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99500489 |
| 106 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98606279 |
| 107 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98552409 |
| 108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97933860 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97674523 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97274337 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96481131 |
| 112 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95186280 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94144336 |
| 114 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93984928 |
| 115 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93873413 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93873350 |
| 117 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93796213 |
| 118 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93761691 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93667080 |
| 120 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93239871 |
| 121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92192870 |
| 122 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92142574 |
| 123 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91653091 |
| 124 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91521601 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91516574 |
| 126 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90470217 |
| 127 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90470217 |
| 128 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89382134 |
| 129 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88298759 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87733570 |
| 131 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87677807 |
| 132 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87329068 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85183325 |
| 134 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83195000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.80991195 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.73850972 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.16319798 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.10296135 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.01048611 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.81683378 |
| 7 | MP0001800_abnormal_humoral_immune | 2.54283631 |
| 8 | MP0001790_abnormal_immune_system | 2.52965610 |
| 9 | MP0005387_immune_system_phenotype | 2.52965610 |
| 10 | MP0003123_paternal_imprinting | 2.48888153 |
| 11 | MP0001348_abnormal_lacrimal_gland | 2.44738095 |
| 12 | MP0005409_darkened_coat_color | 2.39572690 |
| 13 | MP0003724_increased_susceptibility_to | 2.38060983 |
| 14 | MP0004510_myositis | 2.38056910 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.34037882 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.23475576 |
| 17 | MP0009278_abnormal_bone_marrow | 2.22810345 |
| 18 | MP0000685_abnormal_immune_system | 2.16009338 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.07049603 |
| 20 | MP0002009_preneoplasia | 2.03131814 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.95080127 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.92679013 |
| 23 | MP0002822_catalepsy | 1.91290784 |
| 24 | MP0003436_decreased_susceptibility_to | 1.89652426 |
| 25 | MP0001819_abnormal_immune_cell | 1.89542456 |
| 26 | MP0002723_abnormal_immune_serum | 1.88445124 |
| 27 | MP0002419_abnormal_innate_immunity | 1.83342718 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 1.83242521 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.76078784 |
| 30 | MP0005671_abnormal_response_to | 1.74318111 |
| 31 | MP0008569_lethality_at_weaning | 1.73865839 |
| 32 | MP0002398_abnormal_bone_marrow | 1.73058178 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.72827458 |
| 34 | MP0003045_fibrosis | 1.69951166 |
| 35 | MP0003279_aneurysm | 1.67816545 |
| 36 | MP0004947_skin_inflammation | 1.65762460 |
| 37 | MP0003690_abnormal_glial_cell | 1.65691967 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.65415181 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.57017764 |
| 40 | * MP0000716_abnormal_immune_system | 1.56092364 |
| 41 | MP0003122_maternal_imprinting | 1.53726589 |
| 42 | MP0000604_amyloidosis | 1.53188568 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.52298650 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.51489404 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.51027919 |
| 46 | MP0006082_CNS_inflammation | 1.50876429 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.44414575 |
| 48 | * MP0005025_abnormal_response_to | 1.41324455 |
| 49 | MP0003283_abnormal_digestive_organ | 1.38863518 |
| 50 | MP0009046_muscle_twitch | 1.38074350 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.38071024 |
| 52 | MP0010307_abnormal_tumor_latency | 1.37258977 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.35807814 |
| 54 | MP0002722_abnormal_immune_system | 1.34276280 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.33533051 |
| 56 | MP0006054_spinal_hemorrhage | 1.31831998 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.31803958 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.27491342 |
| 59 | MP0002163_abnormal_gland_morphology | 1.25377206 |
| 60 | MP0005310_abnormal_salivary_gland | 1.22409712 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.22285132 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.21192086 |
| 63 | * MP0002429_abnormal_blood_cell | 1.20505070 |
| 64 | MP0001851_eye_inflammation | 1.19666524 |
| 65 | MP0002006_tumorigenesis | 1.18358058 |
| 66 | MP0002405_respiratory_system_inflammati | 1.17856629 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.10721304 |
| 68 | MP0004270_analgesia | 1.09403210 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.08462350 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.08315415 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.07986931 |
| 72 | MP0001188_hyperpigmentation | 1.06955144 |
| 73 | MP0009785_altered_susceptibility_to | 1.06571753 |
| 74 | MP0001270_distended_abdomen | 1.05741261 |
| 75 | MP0008260_abnormal_autophagy | 1.05489421 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.04956842 |
| 77 | MP0003879_abnormal_hair_cell | 1.04514243 |
| 78 | MP0001873_stomach_inflammation | 1.01867335 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.01769239 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.01624194 |
| 81 | MP0003075_altered_response_to | 1.01177151 |
| 82 | MP0003633_abnormal_nervous_system | 1.00232780 |
| 83 | MP0003635_abnormal_synaptic_transmissio | 1.00202310 |
| 84 | MP0009379_abnormal_foot_pigmentation | 0.99414196 |
| 85 | * MP0003866_abnormal_defecation | 0.98843358 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.97784736 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.97301335 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.94456839 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.94421664 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.94181803 |
| 91 | MP0002064_seizures | 0.94069537 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.93392650 |
| 93 | MP0002090_abnormal_vision | 0.92961472 |
| 94 | MP0002063_abnormal_learning/memory/cond | 0.92843381 |
| 95 | MP0000920_abnormal_myelination | 0.92464409 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 0.91894032 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.90347069 |
| 98 | MP0004130_abnormal_muscle_cell | 0.88604658 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.88399055 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.88399055 |
| 101 | MP0003329_amyloid_beta_deposits | 0.87140344 |
| 102 | MP0003091_abnormal_cell_migration | 0.86430853 |
| 103 | MP0003634_abnormal_glial_cell | 0.85152357 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.85102721 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.84952446 |
| 106 | MP0005257_abnormal_intraocular_pressure | 0.82747513 |
| 107 | MP0005166_decreased_susceptibility_to | 0.82163985 |
| 108 | MP0003787_abnormal_imprinting | 0.81827400 |
| 109 | MP0001958_emphysema | 0.81720213 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.81344870 |
| 111 | MP0009840_abnormal_foam_cell | 0.81300224 |
| 112 | MP0004858_abnormal_nervous_system | 0.80443858 |
| 113 | MP0000955_abnormal_spinal_cord | 0.77594668 |
| 114 | MP0002933_joint_inflammation | 0.76290960 |
| 115 | MP0000858_altered_metastatic_potential | 0.75225448 |
| 116 | MP0008004_abnormal_stomach_pH | 0.74132971 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.73440708 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.71412640 |
| 119 | MP0003448_altered_tumor_morphology | 0.70676726 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.70569833 |
| 121 | MP0005390_skeleton_phenotype | 0.70013021 |
| 122 | MP0003828_pulmonary_edema | 0.69980260 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.69916866 |
| 124 | MP0003121_genomic_imprinting | 0.69356213 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.68462011 |
| 126 | MP0000490_abnormal_crypts_of | 0.68403724 |
| 127 | MP0008874_decreased_physiological_sensi | 0.67894466 |
| 128 | MP0000371_diluted_coat_color | 0.67758415 |
| 129 | MP0004885_abnormal_endolymph | 0.67404274 |
| 130 | MP0001849_ear_inflammation | 0.66566223 |
| 131 | MP0001663_abnormal_digestive_system | 0.65768084 |
| 132 | MP0003948_abnormal_gas_homeostasis | 0.65662729 |
| 133 | MP0003705_abnormal_hypodermis_morpholog | 0.65349088 |
| 134 | MP0002067_abnormal_sensory_capabilities | 0.64633594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cellulitis (HP:0100658) | 4.42041334 |
| 2 | Agammaglobulinemia (HP:0004432) | 4.18705662 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.13873460 |
| 4 | Verrucae (HP:0200043) | 3.86088178 |
| 5 | Papilloma (HP:0012740) | 3.86088178 |
| 6 | Colitis (HP:0002583) | 3.85301717 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.53289013 |
| 8 | Recurrent viral infections (HP:0004429) | 3.43585767 |
| 9 | Thyroiditis (HP:0100646) | 3.39917711 |
| 10 | Inflammation of the large intestine (HP:0002037) | 3.27778303 |
| 11 | Gastrointestinal inflammation (HP:0004386) | 3.24486158 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.23958152 |
| 13 | B lymphocytopenia (HP:0010976) | 3.20547543 |
| 14 | Abnormality of B cell number (HP:0010975) | 3.20547543 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04129436 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02156833 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02156833 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02156833 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 2.97799132 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.95983773 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 2.90412169 |
| 22 | Eczematoid dermatitis (HP:0000976) | 2.89375675 |
| 23 | Recurrent bronchitis (HP:0002837) | 2.88251766 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.86451775 |
| 25 | Meningitis (HP:0001287) | 2.77641259 |
| 26 | Spinal cord lesions (HP:0100561) | 2.71811209 |
| 27 | Syringomyelia (HP:0003396) | 2.71811209 |
| 28 | Disinhibition (HP:0000734) | 2.69757488 |
| 29 | Osteomyelitis (HP:0002754) | 2.68959238 |
| 30 | Myositis (HP:0100614) | 2.68903264 |
| 31 | Gastrointestinal stroma tumor (HP:0100723) | 2.58352400 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55401259 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.55401259 |
| 34 | Neuronal loss in central nervous system (HP:0002529) | 2.52668471 |
| 35 | Papilledema (HP:0001085) | 2.52018329 |
| 36 | Loss of speech (HP:0002371) | 2.50562501 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.48345633 |
| 38 | Hematochezia (HP:0002573) | 2.46264827 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45639841 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45639841 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45639841 |
| 42 | Sepsis (HP:0100806) | 2.44025840 |
| 43 | Hyperacusis (HP:0010780) | 2.41358032 |
| 44 | Vertebral arch anomaly (HP:0008438) | 2.40475391 |
| 45 | Annular pancreas (HP:0001734) | 2.39487221 |
| 46 | Increased CSF protein (HP:0002922) | 2.37578890 |
| 47 | Action tremor (HP:0002345) | 2.35866864 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.35532391 |
| 49 | Visual hallucinations (HP:0002367) | 2.34968299 |
| 50 | Orchitis (HP:0100796) | 2.33317322 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31023825 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.30407239 |
| 53 | Obstructive sleep apnea (HP:0002870) | 2.29348170 |
| 54 | Facial diplegia (HP:0001349) | 2.28553436 |
| 55 | Hemiplegia (HP:0002301) | 2.26321974 |
| 56 | Apathy (HP:0000741) | 2.22397986 |
| 57 | Hypercortisolism (HP:0001578) | 2.21260410 |
| 58 | Deep palmar crease (HP:0006191) | 2.20556608 |
| 59 | Macroorchidism (HP:0000053) | 2.19008541 |
| 60 | Hand muscle atrophy (HP:0009130) | 2.18228193 |
| 61 | Diminished motivation (HP:0000745) | 2.16072201 |
| 62 | Neonatal hypoglycemia (HP:0001998) | 2.16005554 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15196588 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.13170360 |
| 65 | Small epiphyses (HP:0010585) | 2.12573020 |
| 66 | Genu recurvatum (HP:0002816) | 2.12199734 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.11802173 |
| 68 | Emphysema (HP:0002097) | 2.10804335 |
| 69 | Hepatoblastoma (HP:0002884) | 2.10625095 |
| 70 | Agitation (HP:0000713) | 2.09743713 |
| 71 | Disproportionate tall stature (HP:0001519) | 2.06628884 |
| 72 | Growth hormone excess (HP:0000845) | 2.06619298 |
| 73 | Asymmetric septal hypertrophy (HP:0001670) | 2.06121944 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04983879 |
| 75 | Hypoventilation (HP:0002791) | 2.04965962 |
| 76 | Chronic otitis media (HP:0000389) | 2.04639902 |
| 77 | Recurrent skin infections (HP:0001581) | 2.03924483 |
| 78 | Diplopia (HP:0000651) | 2.03588926 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.03588926 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.03360861 |
| 81 | Optic neuritis (HP:0100653) | 2.03360861 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.02257473 |
| 83 | Recurrent sinusitis (HP:0011108) | 2.01771101 |
| 84 | Chest pain (HP:0100749) | 1.99837128 |
| 85 | Abnormal pancreas size (HP:0012094) | 1.99808959 |
| 86 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99714435 |
| 87 | Mitral stenosis (HP:0001718) | 1.97533290 |
| 88 | Chronic sinusitis (HP:0011109) | 1.97102703 |
| 89 | Distal upper limb amyotrophy (HP:0007149) | 1.96626362 |
| 90 | Upper limb amyotrophy (HP:0009129) | 1.96626362 |
| 91 | Eosinophilia (HP:0001880) | 1.96017088 |
| 92 | T lymphocytopenia (HP:0005403) | 1.94929225 |
| 93 | Ankle clonus (HP:0011448) | 1.94828789 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94717544 |
| 95 | Abnormality of macrophages (HP:0004311) | 1.94075198 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 1.93955975 |
| 97 | Dysmetric saccades (HP:0000641) | 1.93332236 |
| 98 | Dislocated radial head (HP:0003083) | 1.92961700 |
| 99 | Restrictive lung disease (HP:0002091) | 1.92942698 |
| 100 | Inappropriate behavior (HP:0000719) | 1.92796445 |
| 101 | Increased IgE level (HP:0003212) | 1.90733192 |
| 102 | Mutism (HP:0002300) | 1.90466745 |
| 103 | IgM deficiency (HP:0002850) | 1.90285822 |
| 104 | Global brain atrophy (HP:0002283) | 1.88235318 |
| 105 | Slow saccadic eye movements (HP:0000514) | 1.88100587 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 1.87573325 |
| 107 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86525328 |
| 108 | Spontaneous hematomas (HP:0007420) | 1.85324360 |
| 109 | Enlarged penis (HP:0000040) | 1.85255029 |
| 110 | Hyperparathyroidism (HP:0000843) | 1.85140266 |
| 111 | Persistence of primary teeth (HP:0006335) | 1.85094909 |
| 112 | Truncal ataxia (HP:0002078) | 1.84747263 |
| 113 | Abnormality of the radial head (HP:0003995) | 1.84724331 |
| 114 | Impaired smooth pursuit (HP:0007772) | 1.83967127 |
| 115 | Spinal canal stenosis (HP:0003416) | 1.83436307 |
| 116 | Striae distensae (HP:0001065) | 1.82413523 |
| 117 | Autoimmune thrombocytopenia (HP:0001973) | 1.82165075 |
| 118 | Turricephaly (HP:0000262) | 1.81135415 |
| 119 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80589466 |
| 120 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80589466 |
| 121 | Rectal prolapse (HP:0002035) | 1.80520539 |
| 122 | Nasal polyposis (HP:0100582) | 1.80463415 |
| 123 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80025037 |
| 124 | Obstructive lung disease (HP:0006536) | 1.80025037 |
| 125 | Gingivitis (HP:0000230) | 1.79881173 |
| 126 | Flattened epiphyses (HP:0003071) | 1.79691270 |
| 127 | Postural instability (HP:0002172) | 1.79051636 |
| 128 | Peritonitis (HP:0002586) | 1.77505613 |
| 129 | Fatigue (HP:0012378) | 1.76733080 |
| 130 | Abnormality of T cell number (HP:0011839) | 1.76582856 |
| 131 | Asymmetry of the thorax (HP:0001555) | 1.76561255 |
| 132 | Axonal loss (HP:0003447) | 1.76344353 |
| 133 | Menstrual irregularities (HP:0000858) | 1.75217815 |
| 134 | Periodontitis (HP:0000704) | 1.75115914 |
| 135 | Severe combined immunodeficiency (HP:0004430) | 1.72892105 |
| 136 | Abnormality of the nasal mucosa (HP:0000433) | 1.72480403 |
| 137 | Thoracic kyphosis (HP:0002942) | 1.71716058 |
| 138 | Protrusio acetabuli (HP:0003179) | 1.71563166 |
| 139 | Pulmonary embolism (HP:0002204) | 1.70762413 |
| 140 | Lower limb asymmetry (HP:0100559) | 1.69749250 |
| 141 | Vasculitis (HP:0002633) | 1.68205656 |
| 142 | Thickened calvaria (HP:0002684) | 1.67680105 |
| 143 | Germ cell neoplasia (HP:0100728) | 1.67379481 |
| 144 | Overgrowth (HP:0001548) | 1.67325936 |
| 145 | Mitral valve prolapse (HP:0001634) | 1.67123095 |
| 146 | Hemoptysis (HP:0002105) | 1.66630492 |
| 147 | Pulmonary infiltrates (HP:0002113) | 1.64291805 |
| 148 | Increased variability in muscle fiber diameter (HP:0003557) | 1.64120417 |
| 149 | Abnormality of the right ventricle (HP:0001707) | 1.61951665 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.60471005 |
| 151 | Stomatitis (HP:0010280) | 1.59519607 |
| 152 | Hyperthyroidism (HP:0000836) | 1.59224586 |
| 153 | Lymphopenia (HP:0001888) | 1.58846100 |
| 154 | Long toe (HP:0010511) | 1.58403386 |
| 155 | Thin bony cortex (HP:0002753) | 1.58180093 |
| 156 | Abnormality of the intervertebral disk (HP:0005108) | 1.57862828 |
| 157 | Anomalous pulmonary venous return (HP:0010772) | 1.57062399 |
| 158 | Leukocytosis (HP:0001974) | 1.56545954 |
| 159 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.56464564 |
| 160 | Short 4th metacarpal (HP:0010044) | 1.56464564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.68676348 |
| 2 | PRPF4B | 3.63218476 |
| 3 | TRIB3 | 3.19948502 |
| 4 | RIPK4 | 3.19384926 |
| 5 | MAP4K1 | 2.85193808 |
| 6 | ERN1 | 2.68080057 |
| 7 | EEF2K | 2.67980070 |
| 8 | SIK2 | 2.38881480 |
| 9 | GRK6 | 2.11758871 |
| 10 | PKN2 | 2.07679929 |
| 11 | RIPK1 | 2.06613367 |
| 12 | FES | 2.03220811 |
| 13 | PTK6 | 1.83666802 |
| 14 | CAMKK2 | 1.72103434 |
| 15 | CAMK1G | 1.71910722 |
| 16 | SYK | 1.71755886 |
| 17 | MAP3K11 | 1.71472706 |
| 18 | CAMKK1 | 1.70520712 |
| 19 | FGFR4 | 1.61697868 |
| 20 | WNK1 | 1.60934609 |
| 21 | CSF1R | 1.58029344 |
| 22 | TGFBR2 | 1.48317008 |
| 23 | BTK | 1.45458602 |
| 24 | CAMK1D | 1.44939372 |
| 25 | TYK2 | 1.42740093 |
| 26 | PRKCH | 1.42173412 |
| 27 | SCYL2 | 1.39477698 |
| 28 | EPHB1 | 1.39472627 |
| 29 | JAK1 | 1.38191830 |
| 30 | HCK | 1.35456814 |
| 31 | KIT | 1.34012575 |
| 32 | HIPK2 | 1.31838092 |
| 33 | TXK | 1.30894960 |
| 34 | NTRK1 | 1.26256655 |
| 35 | BLK | 1.25331034 |
| 36 | TBK1 | 1.22859825 |
| 37 | CDK12 | 1.19757038 |
| 38 | TAOK3 | 1.17281295 |
| 39 | NTRK2 | 1.15588460 |
| 40 | ALK | 1.15389057 |
| 41 | PRKD3 | 1.14217163 |
| 42 | LRRK2 | 1.12466649 |
| 43 | PASK | 1.09179032 |
| 44 | SGK3 | 1.07496233 |
| 45 | SMG1 | 1.07188842 |
| 46 | FGFR2 | 1.04155960 |
| 47 | FGFR3 | 1.00923159 |
| 48 | ITK | 1.00665364 |
| 49 | ZAP70 | 0.97250043 |
| 50 | PDK1 | 0.95680077 |
| 51 | SGK223 | 0.94783546 |
| 52 | SGK494 | 0.94783546 |
| 53 | UHMK1 | 0.93268106 |
| 54 | MAP2K2 | 0.92942550 |
| 55 | RPS6KC1 | 0.91966366 |
| 56 | RPS6KL1 | 0.91966366 |
| 57 | MAP3K2 | 0.91718734 |
| 58 | TNK2 | 0.91639086 |
| 59 | RET | 0.90155243 |
| 60 | MAP3K6 | 0.89628156 |
| 61 | MAP3K9 | 0.88524002 |
| 62 | STK10 | 0.88104994 |
| 63 | KSR2 | 0.86931068 |
| 64 | PRKD1 | 0.85823707 |
| 65 | TTN | 0.84004599 |
| 66 | PDGFRA | 0.82648610 |
| 67 | DYRK1B | 0.82047020 |
| 68 | MARK3 | 0.81367200 |
| 69 | CSK | 0.80289881 |
| 70 | JAK2 | 0.80005256 |
| 71 | NLK | 0.79968197 |
| 72 | LCK | 0.76940511 |
| 73 | NEK2 | 0.76675587 |
| 74 | MAP3K13 | 0.76662740 |
| 75 | CDK9 | 0.76415077 |
| 76 | PAK6 | 0.74802318 |
| 77 | MAP3K7 | 0.74689870 |
| 78 | DAPK2 | 0.74502834 |
| 79 | IRAK2 | 0.73244334 |
| 80 | RPS6KA6 | 0.73022043 |
| 81 | LYN | 0.72761459 |
| 82 | MAP2K3 | 0.72134397 |
| 83 | FYN | 0.71766536 |
| 84 | CDK6 | 0.71757847 |
| 85 | MAPK12 | 0.71654927 |
| 86 | SIK1 | 0.70706992 |
| 87 | DMPK | 0.69066649 |
| 88 | PDPK1 | 0.68653479 |
| 89 | MATK | 0.65412470 |
| 90 | STK11 | 0.64424171 |
| 91 | MAP2K4 | 0.63439466 |
| 92 | ICK | 0.63004531 |
| 93 | CAMK4 | 0.60167641 |
| 94 | PRKD2 | 0.59194430 |
| 95 | MARK2 | 0.57775046 |
| 96 | EPHA3 | 0.57335760 |
| 97 | STK38 | 0.57038726 |
| 98 | CDC42BPA | 0.56698162 |
| 99 | NTRK3 | 0.55422874 |
| 100 | SGK2 | 0.55274205 |
| 101 | MAP3K1 | 0.54636003 |
| 102 | CDK4 | 0.54309270 |
| 103 | MAPK7 | 0.53802783 |
| 104 | MAP3K4 | 0.53245291 |
| 105 | MTOR | 0.52889785 |
| 106 | CLK1 | 0.52824672 |
| 107 | LMTK2 | 0.52635405 |
| 108 | SIK3 | 0.52558910 |
| 109 | TIE1 | 0.51925307 |
| 110 | MAP3K14 | 0.51871561 |
| 111 | STK4 | 0.51620141 |
| 112 | TYRO3 | 0.51139708 |
| 113 | PDGFRB | 0.51037386 |
| 114 | STK24 | 0.50999253 |
| 115 | IRAK1 | 0.50182255 |
| 116 | PAK4 | 0.49319079 |
| 117 | EGFR | 0.49308003 |
| 118 | IKBKE | 0.48751511 |
| 119 | RPS6KA2 | 0.48683670 |
| 120 | PIM1 | 0.46131860 |
| 121 | CAMK1 | 0.45587569 |
| 122 | BMX | 0.44509527 |
| 123 | TAOK1 | 0.43771963 |
| 124 | IRAK4 | 0.39149638 |
| 125 | MAPKAPK3 | 0.38252891 |
| 126 | ABL1 | 0.38016790 |
| 127 | SRC | 0.37967337 |
| 128 | MINK1 | 0.37702345 |
| 129 | JAK3 | 0.37380656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.83785980 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03248225 |
| 3 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.92904178 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85555322 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71163558 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67767142 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.64783076 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64428511 |
| 9 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.62649268 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.57763002 |
| 11 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.57164474 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42852996 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41987915 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.40480904 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39709775 |
| 16 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.38058693 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36220936 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32170272 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30605888 |
| 20 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28265381 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27663616 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.27053157 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26929684 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26181613 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25412446 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21646365 |
| 27 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.19510049 |
| 28 | Glioma_Homo sapiens_hsa05214 | 1.17346645 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.17277072 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15853609 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12251293 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11720681 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11384153 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10398467 |
| 35 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.09903347 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09699376 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08695564 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08527764 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06703453 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.04051590 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03102081 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02133428 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.01880313 |
| 44 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01741421 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01615844 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00519276 |
| 47 | Endocytosis_Homo sapiens_hsa04144 | 1.00352865 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00240731 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.97535368 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97125421 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95040094 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 0.94975202 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93930581 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93743722 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93364556 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92557671 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92554179 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.90946955 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90643937 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89183874 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88257468 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87514459 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87457130 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87329806 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.86917192 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.82846735 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.82508154 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82187333 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.80954544 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80494380 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79831964 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79032661 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.78470269 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77938488 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77201680 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76178668 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75654108 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.75414919 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74740315 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73806411 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73563508 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73228467 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.71349356 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70677381 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70572977 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.70554226 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70520036 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70153519 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.69853718 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.69691613 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69021902 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69001355 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68943219 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68221139 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.67808146 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67775749 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67571654 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.67359474 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67037588 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66847643 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.66833332 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.66826279 |
| 103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65309918 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.65256814 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64912624 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64598136 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63791396 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63381348 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62783869 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62586772 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62424398 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62381725 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61226159 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60828193 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60783548 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.60537589 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.59662147 |
| 118 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58714717 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.58049057 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57867908 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57338707 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57212960 |

